The role of focal-adhesion kinase in cancer - A new therapeutic opportunity

Nature Reviews Cancer

Volumn 5, Issue 7, 2005, Pages 505-515

  McLean, Gordon W ^a   Carragher, Neil O ^a   Avizienyte, Egle ^a   Evans, Jeff ^a   Brunton, Valerie G ^a   Frame, Margaret C ^a  

^a BEATSON INSTITUTE FOR CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; ADAPTOR PROTEIN; CADHERIN; CALPAIN; EPIDERMAL GROWTH FACTOR; FOCAL ADHESION KINASE; GELATINASE A; GROWTH FACTOR; GROWTH FACTOR RECEPTOR; INTEGRIN; MESSENGER RNA; PLATELET DERIVED GROWTH FACTOR; PROTEIN P53; PROTEIN TYROSINE KINASE; STRESS ACTIVATED PROTEIN KINASE;

APOPTOSIS; CANCER CELL; CANCER GROWTH; CANCER INVASION; CANCER MODEL; CARCINOGENESIS; CELL ADHESION; CELL CYCLE; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; CELL PROTECTION; CELL SURVIVAL; CONFORMATIONAL TRANSITION; CYTOSKELETON; DRUG TARGETING; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME PHOSPHORYLATION; FOCAL ADHESION; HUMAN; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; SKIN CARCINOGENESIS;

ANIMALS; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; DISEASE PROGRESSION; FOCAL ADHESION KINASE 1; FOCAL ADHESION PROTEIN-TYROSINE KINASES; HUMANS; MICE; MODELS, ANIMAL; NEOPLASMS; PROTEIN-TYROSINE KINASES; SIGNAL TRANSDUCTION;

EID: 21744435478     PISSN: 1474175X     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrc1647     Document Type: Review

References (122)

1. Carragher, N. O. & Frame, M. C. Focal adhesion and actin dynamics: a place where kinases and proteases meet to promote invasion. Trends Cell Biol. 14, 241-249(2004).
2. Weiner, T. M., Liu, E. T., Craven, R. J. & Cance, W. G. Expression of focal adhesion kinase gene and invasive cancer. Lancer 342, 1024-1025 (1993).
3. FAK) in invasive human tumours. Cancer Res. 55, 2752-2755 (1995).
4. Owens, L. V. et al. Focal adhesion kinase as a marker of invasive potential in differentiated human thyroid cancer. Ann. Surg. Oncol. 3, 100-105 (1996).
5. CSK in human metastatic prostate carcinoma. Int. J. Cancer 68, 164-171 (1996).
6. McCormack, S. J., Brazinski, S. E., Moore, J. L. Jr, Werness, B. A. & Goldstein, D. J. Activation of the focal adhesion kinase signal transduction pathway in cervical carcinoma cell lines and human genital epithelial cells immortalized with human papillomavirus type 18. Oncogene 15, 265-274 (1997).
7. Kornberg, L. J. Focal adhesion kinase expression in oral cancers. Head Neck 20, 634-639 (1998).
8. Kornberg, L. J. Focal adhesion kinase and its potential involvement in tumour invasion and metastasis. Head Neck 20, 745-752 (1998).
9. Judson, P. L., He, X., Cance, W. G. & Van Le, L. Overexpression of focal adhesion kinase, a protein tyrosine kinase, in ovarian carcinoma. Cancer 86, 1551-1556 (1999).
10. Cance, W. G. et al. Immunohistochemical analyses of focal adhesion kinase expression in benign and malignant human breast and colon tissues: correlation with preinvasive and invasive phenotypes. Clin. Cancer Res. 6, 2417-2423 (2000).
11. Lark, A. L. et al. Overexpression of focal adhesion kinase in primary colourectal carcinomas and colorectal liver metastases: immunohistochemistry and real-time PCR analyses. Clin. Cancer Res. 9, 215-222 (2003).
12. Gabriel, B. et al. Focal adhesion kinase interacts with the transcriptional co-activator FHL2 and both are overexpressed in epithelial ovarian cancer. Anticancer Res. 24, 921-927 (2004).
13. Recher, C. et al. Expression of focal adhesion kinase In acute myeloid leukemia is associated with enhanced blast migration, increased cellularity, and poor prognosis. Cancer Res. 64, 3191-3197 (2004).
14. Sohlaepfer, D. D., Mitra, S. K. & Ilic, D. Control of motile and invasive cell phenotypes by focal adhesion kinase. Biochim. Biophys. Acta 1692, 77-102 (2004).
15. Sood, A. K. et al. Biological significance of focal adhesion kinase in ovarian cancer: role in migration and invasion. Am. J. Pathol. 165, 1087-1095 (2004).
16. Ayaki, M. et al. Reduced expression of focal adhesion kinase in liver metastases compared with matched primary human colourectal adenocarcinomas. Clin. Cancer Res. 7, 3106-3112 (2001).
17. Agochiya, M. et al. Increased dosage and amplification of the focal adhesion kinase gene in human cancer cells. Oncogene 18, 5646-5653 (1999).
18. Golubovskaya, V., Kaur, A., & Cance, W. Cloning and characterization of the promoter region of human focal adhesion kinase gene: nuclear factor κB and p53 binding sites. Biochim. Biophys. Acta 1678, 111-125 (2004).
19. Mitra, S. K., Hanson, D. A. & Schlaepfer, D. D. Focal adhesion kinase: in command and control of cell motility. Nature Rev. Mol. Cell Biol. 6, 56-68 (2005).
20. Schlaepfer, D. D., Hanks, S. K., Hunter, T. & van der Geer, P. Integrin-mediated signal transduction linked to Ras pathway by GRB2 binding to focal adhesion kinase. Nature 372, 786-791 (1994).
21. Schaller, M. D. et al. Autophosphorylation of the focal adhesion kinase, pp125FAK, directs SH2-dependent binding of pp60src. Mol. Cell. Biol. 14, 1680-1688 (1994).
22. Calalb, M. B., Polte, T. R. & Hanks, S. K. Tyrosine phosphorylation of focal adhesion kinase at sites in the catalytic domain regulates kinase activity: a role for Src family kinases. Mol. Cell. Biol. 15, 954-963 (1995).
23. Calalb, M. B., Zhang, X., Polte, T. R. & Hanks, S. K. Focal adhesion kinase tyrosine-861 is a major site of phosphorylation by Src. Biochem. Biophys. Res. Commun. 228, 662-668 (1996).
24. Schlaepfer, D. D. & Hunter, T. Evidence for in vivo phosphorylation of the Grb2 SH2-domain binding site on focal adhesion kinase by Src-family protein-tyrosine kinases. Mol. Cell. Biol. 16, 5623-5633 (1996).
25. Grisaru-Granovsky, S. et al. Differential expression of Protease activated receptor 1 (Par1) and pY397FAK in benign and malignant human ovarian tissue samples. Int. J. Cancer 113, 372-378 (2004).
26. Aronsohn, M. S., Brown, H. M., Hauptman, G. & Kornberg, L. J. Expression of focal adhesion kinase and phosphorylated focal adhesion kinase in squamous cell carcinoma of the larynx. Laryngoscope 113, 1944-1948 (2003).
27. Moon, H. S., Park, W. I., Choi, E. A., Chung, H. W. & Kim, S. C. The expression and tyrosine phosphorylation of E-cadherin/catenin adhesion complex, and focal adhesion kinase in invasive cervical carcinomas. Int. J. Gynecol. Cancer 13, 640-646 (2003).
28. Brunton, V. G. et al. Identification of Src-specific phosphorylation site on FAK: dissection of the role of Src SH2 and catalytic functions and their consequences for tumour cell behaviour. Cancer Res. 65, 1335-1342 (2005).
29. -/- cells, the authors demonstrate that FAK links growth-factor receptors to integrin-controlled cell motility. However FAK is likely to have the role of adaptor or scaffold as Its kinase activity might be dispensable for this role.
30. Matkowskyj, K, A. et al. Expression of GRP and its receptor in well-differentiated colon cancer cells correlates with the presence of focal adhesion kinase phosphorylated at tyrosines 397 and 407. J. Histochem. Cytochem. 51, 1041-1048 (2003).
31. Avizienyte, E. et al. Src-induced de-regulation of E-cadherin in colon cancer cells requires integrin signalling. Nature Cell Biol. 4, 632-638 (2002). Demonstrated a requirement for SRC-mediated phosphorylation of FAK in the deregulation of E-cadherin-based cell-cell junctions in colon cancer cells. This paper linked integrin-induced signals to adhesion changes at cell junctions and provides evidence that FAK signalling could be important for the disassembly of cell-cell junctions that is associated with the epithelial-mesenchymal transition, and therefore perhaps invasion.
32. Eliceiri, B. P. et al. Src-mediated coupling of focal adhesion kinase to integrin αvβ5 in vascular endothelial growth factor signalling. J. Cell Biol. 157, 149-160(2002).
33. Chen, H. C., Chan, P. C., Tang, M. J., Cheng, C. H. & Chang, T. J. Tyrosine phosphorylation of focal adhesion kinase stimulated by hepatocyte growth factor leads to mitogen-activated protein kinase activation. J. Biol. Chem. 273, 25777-25782 (1998).
34. Nakamura, K., Yano, H., Schaefer, E. & Sabe, H. Different modes and qualities of tyrosine phosphorylation of Fak and Pyk2 during epithelial-mesenchymal transdifferentiation and cell migration: analysis of specific phosphorylation events using site-directed antibodies. Oncogene 20, 2626-2635 (2001).
35. Lim, Y. et al. Phosphorylation of focal adhesion kinase at tyrosine 861 is crucial for Ras transformation of fibroblasts. J. Biol. Chem. 279, 29060-29065 (2004).
36. Parsons, J. T., Martin, K. H., Slack, J. K. Taylor, J. M. & Weed, S. A. Focal adhesion kinase: a regulator of focal adhesion dynamics and cell movement. Oncogene 19, 5606-5613 (2000).
37. -/- fibroblasts was sufficient to restore migration defects, FAK re-expression and the formation of a FAK-SRC-CAS-DOCK180 complex was necessary to promote invasion.
38. FAK. Nature 380, 538-540 (1996).
39. Webb, D. J. et al. FAK-Src signalling through paxillin, ERK and MLCK regulates adhesion disassembly. Nature Cell Biol. 6, 154-161 (2004).
40. Carragher, N. O., Westhoff, M. A., Fincham, V. J., Schaller, M. D. & Frame, M. C. A novel role for FAK as a protease-targeting adaptor protein: regulation by p42 ERK and Src. Curr. Biol. 13, 1442-1450 (2003).
41. Ilic, D. et al. Reduced cell motility and enhanced focal adhesion contact formation in cells from FAK-deficient mice. Nature 377, 539-544 (1995).
42. Ren, X. D. et al. Focal adhesion kinase suppresses Rho activity to promote focal adhesion turnover. J. Cell Sci. 113, 3673-3678 (2000).
43. Franco, S., Perrin, B. & Huttenlocher, A. Isoform specific function of calpain 2 in regulating membrane protrusion. Exp. Cell Res. 299, 179-187 (2004).
44. Huttenlocher, A. et al. Regulation of cell migration by the calcium-dependent protease calpain. J. Biol. Chem. 272, 32719-32722 (1997).
45. FAK, paxillin, and talin. J. Cell Biol. 147, 619-630 (1999).
46. Carragher, N. O., Fincham, V. J., Riley, D. & Frame, M. C. Cleavage of focal adhesion kinase by different proteases during SRC-regulated transformation and apoptosis. Distinct roles for calpain and caspases. J. Biol. Chem. 276, 4270-4275 (2001).
47. Franco, S. J. et al. Calpain-mediated proteolysis of talin regulates adhesion dynamics. Nature Cell Biol. 6, 977-983 (2004).
48. Glading, A. et al. Epidermal growth factor activates m-calpain (calpain II), at least in part, by extracellular signal-regulated kinase-mediated phosphorylation. Mol. Cell. Biol. 24, 2499-2512 (2004).
49. Westhoff, M. A., Serrels, B., Fincham, V. J., Frame, M. C. & Carragher, N. O. SRC-mediated phosphorylation of focal adhesion kinase couples actin and adhesion dynamics to survival signalling. Mol. Cell. Biol. 24, 8113-8133 (2004).
50. Sebolt-Leopold, J. S. Development of anticancer drugs targeting the MAP kinase pathway. Oncogens 19, 6594-6599 (2000).
51. Mamoune, A. et al. DU145 human prostate carcinoma invasiveness is modulated by urokinase receptor (uPAR) downstream of epidermal growth factor receptor (EGFR) signalling. Exp. Cell Res. 299, 91-100 (2004).
52. Braun, C. et al. Expression of calpain I messenger RNA in human renal cell carcinoma: correlation with lymph node metastasis and histological type. Int. J. Cancer 84, 6-9 (1999).
53. Frame, M. C. Src in cancer: deregulation, and consequences for cell behaviour. Biochim. Biophys. Acta 1602, 114-130 (2002).
54. McLean, G. W., Avizienyte, E. & Frame, M. C. Focal adhesion kinase as a potential target in oncology. Expert Opin. Pharmacother. 4, 227-234 (2003).
55. 2-terminal kinase. J. Cell Biol. 149, 741-754 (2000).
56. Huang, C., Rajfur, Z., Borchers, C., Schaller, M. D. & Jacobson, K. JNK phosphorylates paxillin and regulates cell migration. Nature 424, 219-223 (2003).
57. Subauste, M. C. et al. Vinculin modulation of paxillin-FAK interactions regulates ERK to control survival and motility. J. Cell Biol. 165, 371-381 (2004).
58. Schaller, M, D. Biochemical signals and biological responses elicited by the focal adhesion kinase. Biochim. Biophys. Acta 1540, 1-21 (2001).
59. Cas as a mediator of focal adhesion kinase-promoted cell migration. J. Cell Biol. 140, 211-221 (1998).
60. Sieg, D, J., Hauck, C. R. & Schlaepfer, D. D. Required role of focal adhesion kinase (FAK) for integrin-stimulated cell migration. J. Cell Sci. 112, 2677-2691 (1999).
61. Haskell, H. et al. Focal adhesion kinase is expressed in the angiogenic blood vessels of malignant astrocytic tumours in vivo and promotes capillary tube formation of brain microvascular endothelial cells. Clin. Cancer Res. 9, 2157-2165 (2003).
62. Ilic, D. et al. FAK promotes organization of fibronectin matrix and fibrillar adhesions. J. Cell Sci. 117, 177-187 (2004).
63. Chen, B. H., Tzen, J. T., Bresnick, A. R. & Chen, H. C. Roles of Rho-associated kinase and myosin light chain kinase in morphological and migratory defects of focal adhesion kinase-null cells. J. Biol. Chem. 277, 33857-33863 (2002).
64. Zhai, J. et al. Direct interaction of focal adhesion kinase with p190RhoGEF. J. Biol. Chem. 278, 24865-24873 (2003).
65. Liu, Y., Loijens, J. C., Martin, K. H., Karginov, A. V. & Parsons, J. T. The association of ASAP1, an ADP ribosylation factor-GTPase activating protein, with focal adhesion kinase contributes to the process of focal adhesion assembly. Mol. Biol. Cell 13, 2147-2156 (2002).
66. Hildebrand, J. D., Taylor, J. M. & Parsons, J. T. An SH3 domain-containing GTPase-activating protein for Rho and Cdc42 associates with focal adhesion kinase. Mol. Cell. Biol. 16, 3169-3178 (1996).
67. Parsons, J. T. Focal adhesion kinase: the first ten years. J. Cell Sci. 116, 1409-1416 (2003).
68. Brugnera, E. et al. Unconventional Rac-GEF activity is mediated through the Dock180-ELMO complex. Nature Cell Biol. 4, 574-582 (2002).
69. Wu, X., Suetsugu, S., Cooper, L. A., Takenawa, T. & Guan, J. L. Focal adhesion kinase regulation of N-WASP subcellular localization and function, J. Biol., Chem. 279, 9565-9576 (2004).
70. Hauck, C. R., Hsia, D. A., Ilic, D. & Schlaepfer, D. D. v-Src SH3-enhanced interaction with focal adhesion kinase at β1 integrin-containing invadopodia promotes cell invasion. J. Biol. Chem. 277, 12487-12490 (2002).
71. Lu, Z., Jiang, G., Blume-Jensen, P. & Hunter, T. Epidermal growth factor-induced tumour cell invasion and metastasis initiated by dephosphorylation and downregulation of focal adhesion kinase. Mol. Cell. Biol. 21, 4016-4031 (2001).
72. Cukierman, E., Pankov, R., Stevens, D. R. & Yamada, K. M. Taking cell-matrix adhesions to the third dimension. Science 294, 1708-1712 (2001).
73. Yamada, K. M., Pankov, R. & Cukierman, E. Dimensions and dynamics in integrin function. Braz. J. Med Biol. Res. 36, 959-966 (2003).
74. Ilic, D, et al. Plasma membrane-associated pY397FAK is a marker of cytotrophoblast invasion in vivo and in vitro. Am. J. Pathol. 159, 93-108 (2001). Showed that FAK was phosphorylated on Y397 during cytotrophoblast invasion of surrounding ECM. Knocking down FAK expression suppressed cytotrophoblast invasion, showing that FAK signalling, and autophosphorylation in particular, is also associated with normal invasive processes.
75. Moissoglu, K. & Gelman, I. H. v-Src rescues actin-based cytoskeletal architecture and cell motility and induces enhanced anchorage independence during oncogenic transformation of focal adhesion kinase-null fibroblasts. J. Biol. Chem. 278, 47946-47959 (2003).
76. Zhang, Y. et al. A role for focal adhesion kinase in hyluronan-dependent MMP-2 secretion in a human small-cell lung carcinoma cell line, QG90. Biochem. Biophys. Res. Commun. 290, 1123-1127 (2002).
77. Shibata, K. et al. Both focal adhesion kinase and c-Ras are required for the enhanced matrix metalloproteinase 9 secretion by fibronectin in ovarian cancer cells. Cancer Res. 58, 900-903 (1998).
78. Wolf, K. et al. Compensation mechanism in tumour cell migration: mesenchymal-amoeboid transition after blocking of pericellular proteolysis. J. Cell Biol. 160, 267-277 (2003).
79. Sahai, E. & Marshall, C. J. Differing modes of tumour cell invasion have distinct requirements for Rho/ROCK signalling and extracellular proteolysis. Nature Cell Biol. 5, 711-719 (2003).
80. Friedl, P. & Wolf, K. Tumour-cell invasion and migration: diversity and escape mechanisms. Nature Rev. Cancer 3, 362-374 (2003).
81. Friedl, P. Prespecification and plasticity: shifting mechanisms of cell migration. Curr. Opin. Cell Biol. 16, 14-23 (2004).
82. Yano, H. et al. Roles played by a subset of integrin signalling molecules in cadherin-based cell-cell adhesion. J. Cell Biol. 166, 283-295 (2004).
83. Wang, H., Radjendirane, V., Wary, K. K. & Chakrabarty, S. Transforming growth factor β regulates cell-cell adhesion through extracellular matrix remodeling and activation of focal adhesion kinase in human colon carcinoma Moser cells. Oncogene 23, 5558-5561 (2004).
84. Quadri, S. K., Bhattacharjee, M., Parthasarathi, K., Tanita, T. & Bhattaoharya, J. Endothelial barrier strengthening by activation of focal adhesion kinase. J. Biol. Chem. 278, 13342-13349 (2003).
85. Frisch, S. M., Vuori, K., Ruoslahti, E. & Chan-Hui, P. Y. Control of adhesion-dependent cell survival by focal adhesion kinase. J. Cell Biol. 134, 793-799 (1996).
86. Chan, P. C. et al. Suppression of ultraviolet irradiation-induced apoptosis by overexpression of focal adhesion kinase in Madin-Darby canine kidney cells. J. Biol. Chem. 274, 26901-26906 (1999).
87. Sonoda, Y. et al. Anti-apoptotic role of focal adhesion kinase (FAK). Induction of inhibitor-of-apoptosis proteins and apoptosis suppression by the overexpression of FAK in a human leukemic cell line, HL-60. J. Biol. Chem. 275, 16309-16315 (2000).
88. Sakurai, S. et al. Mutated focal adhesion kinase induces apoptosis in a human glioma cell line, T98G. Biochem. Biophys. Res. Commun. 293, 174-181 (2002).
89. Liu, X. J. et al. Apoptosis of rat hepatic stellate cells induced by anti-focal adhesion kinase antibody. World J. Gastroenterol. 8, 734-738 (2002).
90. Hungerford, J. E., Compton, M. T., Matter, M. L., Hoffstrom, B. G. & Otey, C. A. Inhibition of pp125FAK in cuitured fibroblasts results in apoptosis. J. Cell Biol. 135, 1333-1390 (1996).
91. Xu, L. H. et al. Attenuation of the expression of the focal adhesion kinase induces apoptosis in tumour cells. Cell Growth Differ. 7, 413-418 (1996).
92. van de Water, B., Houtepen, F, Huigsloot, M. & Tijdens, I. B. Suppression of chemically induced apoptosis but not necrosis of renal proximal tubular epithelial (LLC-PK1) cells by focal adhesion kinase (FAK). Role of FAK in maintaining focal adhesion organization after acute renal cell injury. J. Biol. Chem. 276, 36183-36193 (2001).
93. Jones, G., Machado, J. Jr, Tolnay, M. & Merlo, A. PTEN-independent induction of caspase-mediated cell death and reduced invasion by the focal adhesion targeting domain (FAT) in human astrocytic brain tumours which highly express focal adhesion kinase (FAK). Cancer Res. 61, 5688-5691 (2001).
94. Ilic, D. et al. Extracellular matrix survival signals transduced by focal adhesion kinase suppress p53-mediated apoptosis. J. Cell Biol. 143, 547-560 (1998).
95. Golubovskaya, V. et al. Dual inhibition of focal adhesion kinase and epidermal growth factor receptor pathways cooperatively induces death receptor-mediated apoptosis in human breast cancer cells. J. Biol. Chem. 277, 38978-38987 (2002).
96. Golubovskaya, V. M. et al. Simultaneous inhibition of focal adhesion kinase and SRC enhances detachment and apoptosis in colon cancer cell lines. Mol. Cancer Res. 1, 755-764 (2003).
97. Xu, L. H. et al. The focal adhesion kinase suppresses transformation-associated, anchorage-independent apoptosis in human breast cancer cells. Involvement of death receptor-related signalling pathways. J. Biol. Chem. 275, 30597-30604 (2000).
98. Beviglia, L. et al. Focal adhesion kinase N-terminus in breast carcinoma cells induces rounding, detachment and apoptosis. Biochem. J. 373, 201-210 (2003).
99. Kurenova, E. et al. Focal adhesion kinase suppresses apoptosis by binding to the death domain of receptor-interacting protein. Mol. Cell. Biol. 24, 4361-4371 (2004). Provides new mechanistic insight into the role of FAK as a suppressor of apoptosis by providing evidence of a link between FAK and the death-receptor complex. FAK is shown to bind to RIP (a pro-apoptotic member of the death-receptor complex) and inhibit its function, so providing a possible link between the overexpression of FAK found in many tumours and aberrantly regulated survival signalling.
100. Duxbury, M. S., Ito, H., Zinner, M. J., Ashley, S. W. & Whang, E. E. Focal adhesion kinase gene silencing promotes anoikis and suppresses metastasis of human pancreatic adenocarcinoma cells. Surgery 135, 555-562 (2004). Highlights the possible therapeutic benefit of FAK gene silencing. In pancreatic cell lines FAK RNAi resulted in death of anoikis-resistant resistant cell lines, and in suppression of metastasis.
101. Duxbury, M. S. et al. RNA interference targeting focal adhesion kinase enhances pancreatic adenocarcinoma gemcitabine chemosensitivity. Biochem. Biophys. Res. Commun. 311, 786-792 (2003).
102. Sethi, T. et al. Extracellular matrix proteins protect small cell lung cancer cells against apoptosis: a mechanism for small cell lung cancer growth and drug resistance in vivo. Nature Med. 5, 662-668 (1999).
103. Aguirre Ghiso, J. A. Inhibition of FAK signalling activated by urokinase receptor induces dormancy in human carcinoma cells in vivo. Oncogene 21, 2513-2524 (2002).
104. Hecker, T. P., Grammer, J. R., Gillespie, G. Y., Stewart, J. Jr. & Gladson, C. L. Focal adhesion kinase enhances signalling through the Shc/extracellular signal-regulated kinase pathway in anaplastic astrocytoma tumour biopsy samples. Cancer Res. 62, 2699-26707 (2002).
105. Hecker, T. P., Ding, Q., Rege, T. A., Hanks, S. K. & Gladson, C. L. Overexpression of FAK promotes Ras activity through the formation of a FAK/p120RasGAP complex in malignant astrocytoma cells. Oncogene 23, 3962-3971 (2004).
106. Quintanilla, M., Brown, K., Ramsden, M. & Balmain, A. Carcinogen-specific mutation and amplification of Ha-ras during mouse skin carcinogenesis. Nature 322, 78-80 (1986).
107. McLean, G. W. et al. Decreased focal adhesion kinase suppresses papilloma formation during experimental mouse skin carcinogenesis. Cancer Res. 61, 8385-8389 (2001).
108. Indra, A. K, et al. Temporally-controlled site-specific mutagenesis in the basal layer of the epidermis: comparison of the recombinase activity of the tamoxifen-inducible Cre-ER(T) and Cre-ER(T2) recombinases. Nucleic Acids Res. 27, 4324-4327 (1999).
109. McLean, G. W. et al. Specific deletion of focal adhesion kinase suppresses tumour formation and blocks malignant progression. Genes Dev. 18, 2998-3003 (2004). Using a mouse skin carcinogenesis model and skin-specific conditional FAK deletion, this report provides the first in vivo evidence for a causative role for FAK during tumour progression. Cre-LOX driven FAK ablation both reduced benign papilloma formation and blocked progression to malignant squamous-cell carcinoma, an effect that was shown to be linked to the anti-apoptotic function of FAK.
110. Hanks, S. K., Ryzhova, L., Shin, N. Y. & Brabek, J. Focal adhesion kinase signalling activities and their implications in the control of cell survival and motility. Front Biosci. 8, 982-996 (2003).
111. Duan, W. R. et al. Comparison of immunohistochemistry for activated caspase-3 and cleaved cytokeratin 18 with the TUNEL method for quantification of apoptosis in histological sections of PC-3 subcutaneous xenografts. J. Pathol. 199, 221-228 (2003).
112. Marshman, E., Ottewell, P. D., Potten, C. S. & Watson, A. J. Caspase activation during spontaneous and radiation-induced apoptosis in the murine intestine. J. Pathol. 195, 285-292 (2001).
113. Argyris, T. S. Tumour promotion by abrasion induced epidermal hyperplasia in the skin of mice. J. Invest. Dermatol. 75, 360-362 (1980).
114. Miyazaki, T. et al. FAK overexpression is correlated with tumour invasiveness and lymph node metastasis in oesophageal squamous cell carcinoma. Br. J. Cancer 89, 140-145 (2003).
115. Gary, L. A., Chang, J. F. & Guan, J. L. Stimulation of cell migration by overexpression of focal adhesion kinase and its association with Src and Fyn. J. Cell Sci. 109, 1787-1794 (1996).
116. Sawyer, T., Boyce, B., Dalgarno, D, & Iuliucci, J. Src inhibitors: genomics to therapeutics. Expert Opin. Investig. Drugs 10, 1327-1344 (2001).
117. Gay, B, et al. Selective GRB2 SH2 inhibitors as anti-Ras therapy. Int. J. Cancer 83, 235-241 (1999).
118. Katz, B. Z. et al. Targeting membrane-localized focal adhesion kinase to focal adhesions: roles of tyrosine phosphorylation and SRC family kinases. J. Biol. Chem. 278, 29115-29120 (2003).
119. Avizienyte, E., Fincham, V. J., Brunton, V. G. & Frame, M. C. Src SH3/2 domain-mediated peripheral accumulation of Src and phospho-myosin is linked to deregulation of E-cadherin and the epithelial-mesenchymal transition. Mol. Biol. Cell 15, 2794-2803 (2004).
120. Chikumi, H., Fukuhara, S. & Gutkind, J. S. Regulation of G protein-linked guanine nucleotide exchange factors for Rho, PDZ-RhoGEF, and LARG by tyrosine phosphorylation: evidence of a role for focal adhesion kinase. J. Biol. Chem. 277, 12463-12473 (2002).
121. Hauck, C. R., Hsia, D. A., Puente, X. S., Cheresh, D. A. & Schlaepfer, D. D. FRNK blocks v-Src-stimulated invasion and experimental metastases without effects on cell motility or growth. EMBO J. 21, 6289-6302 (2002).
122. van Nimwegen, M. J., Verkoeijen, S., van Buren, L., Burg, D. & van de Water, B. Requirement for focal adhesion kinase in the early phase of mammary adenocarcinoma lung metastasis formation. Cancer Res. 65, 4698-4706 (2005).